Tatva Chintan Pharma Chem Ltd
BSE: 543321
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 146.70+10.6% | 132.66-4.3% | 138.59+19.6% | 115.86+6.1% | 109.18+1.4% | 107.65+28.2% | 84.00+3.8% | 80.96 |
| Other Income | 4.03+1193.0% | -0.37-121.3% | 1.73+118.4% | 0.79-42.0% | 1.37+5.7% | 1.29+3137.5% | 0.04-95.1% | 0.81 |
| Total Income | 150.74+13.9% | 132.30-5.7% | 140.32+20.3% | 116.66+5.5% | 110.55+1.5% | 108.94+29.6% | 84.04+2.8% | 81.77 |
| EXPENSES | ||||||||
| Expenditure | 135.32+15.3% | 117.32-3.5% | 121.53+16.5% | 104.31+0.8% | 103.50-3.6% | 107.39+25.3% | 85.69+2.8% | 83.34 |
| Tax | 3.65-38.7% | 5.95+112.0% | 2.81-17.5% | 3.40+77.1% | 1.92+318.5% | 0.46-5.9% | 0.49+3.8% | 0.47 |
| PROFIT | ||||||||
| PBT | 14.09-5.9% | 14.97-20.3% | 18.79+52.2% | 12.34+75.0% | 7.05+353.9% | 1.55+194.0% | -1.65-4.6% | -1.58 |
| Net Profit | 10.45+15.8% | 9.02-43.5% | 15.98+78.8% | 8.94+74.2% | 5.13+368.8% | 1.09+194.0% | -1.17-5.0% | -1.11 |
| KEY METRICS | ||||||||
| OPM % | 15.48%-4.52pp | 20.00%+0.79pp | 19.21%+0.99pp | 18.22%+4.42pp | 13.80%+6.46pp | 7.34%+18.09pp | -10.75%-8.80pp | -1.95% |
| NPM % | 6.93%+0.11pp | 6.82%-4.57pp | 11.39%+3.73pp | 7.66%+3.02pp | 4.64%+3.63pp | 1.01%+2.40pp | -1.39%-0.02pp | -1.37% |
| EPS | 4.47+15.8% | 3.86-43.6% | 6.84+79.1% | 3.82+74.4% | 2.19+366.0% | 0.47+194.0% | -0.50-900.0% | -0.05 |
Corporate Events
Board MeetingTATVA
202617Jul
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingTATVA
202616May
Board Meeting
The Board of Directors of Tatva Chintan Pharma Chem Limited …
BSE Filing ↗ Board MeetingTATVA
202425Oct
Board Meeting
Consider, approve and take on record the Standalone and Cons…
BSE Filing ↗ Board MeetingTATVA
202420Jan
Board Meeting
Consider and approve and take on record the Standalone and C…
BSE Filing ↗ Board MeetingTATVA
20232Nov
Board Meeting
Consider and approve and take on record the Standalone and C…
BSE Filing ↗